Literature DB >> 27929101

Hookworm infection.

Alex Loukas1, Peter J Hotez2,3,4, David Diemert5,6, Maria Yazdanbakhsh7, James S McCarthy8,9, Rodrigo Correa-Oliveira10, John Croese1,11, Jeffrey M Bethony5.   

Abstract

Hookworms are soil-transmitted nematode parasites that can reside for many years in the small intestine of their human hosts; Necator americanus is the predominant infecting species. Adult worms feed on the blood of a host and can cause iron deficiency anaemia, especially in high-risk populations (children and women of childbearing age). Almost 500 million people in developing tropical countries are infected, and simulation models estimate that hookworm infection is responsible for >4 million disability-adjusted life years lost annually. Humans mount an immune response to hookworms, but it is mostly unsuccessful at removing adult worms from the bowel. Accordingly, the host switches to an immune-tolerant state that enables hookworms to reside in the gut for many years. Although anthelmintic drugs are available and widely used, their efficacy varies and the drugs do not prevent reinfection. Thus, other control strategies aimed at improving water quality, sanitation and hygiene are needed. In addition, efforts are underway to develop a human hookworm vaccine through public-private partnerships. However, hookworms could also be a resource; as hookworms have the capability to regulate the host's inflammation, researchers are experimentally infecting patients to treat some inflammatory diseases as an approach to discover new anti-inflammatory molecules. This area of endeavour might well yield new biotherapeutics for autoimmune and allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27929101     DOI: 10.1038/nrdp.2016.88

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  71 in total

1.  Hookworm-Derived Metabolites Suppress Pathology in a Mouse Model of Colitis and Inhibit Secretion of Key Inflammatory Cytokines in Primary Human Leukocytes.

Authors:  Phurpa Wangchuk; Catherine Shepherd; Constantin Constantinoiu; Rachael Y M Ryan; Konstantinos A Kouremenos; Luke Becker; Linda Jones; Geraldine Buitrago; Paul Giacomin; David Wilson; Norelle Daly; Malcolm J McConville; John J Miles; Alex Loukas
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

2.  Regulation of human THP-1 macrophage polarization by Trichinella spiralis.

Authors:  Anna Zawistowska-Deniziak; Justyna Bień-Kalinowska; Katarzyna Basałaj
Journal:  Parasitol Res       Date:  2021-01-08       Impact factor: 2.289

3.  Pharmacological characterization of a homomeric nicotinic acetylcholine receptor formed by Ancylostoma caninum ACR-16.

Authors:  Shivani Choudhary; James G Tipton; Melanie Abongwa; Matthew T Brewer; Jeba Jesudoss Chelladurai; Nicole Musselman; Richard J Martin; Alan P Robertson
Journal:  Invert Neurosci       Date:  2019-09-05

Review 4.  Immunity to gastrointestinal nematode infections.

Authors:  D Sorobetea; M Svensson-Frej; R Grencis
Journal:  Mucosal Immunol       Date:  2018-01-03       Impact factor: 7.313

5.  Expedient on-resin synthesis of peptidic benzimidazoles.

Authors:  Michael J Bird; Anthony P Silvestri; Philip E Dawson
Journal:  Bioorg Med Chem Lett       Date:  2018-05-03       Impact factor: 2.823

6.  Albendazole resistance induced in Ancylostoma ceylanicum is not due to single-nucleotide polymorphisms (SNPs) at codons 167, 198, or 200 of the beta-tubulin gene, indicating another resistance mechanism.

Authors:  Luis Fernando Viana Furtado; Pedro Henrique Nascimento de Aguiar; Luciana Werneck Zuccherato; Talita Tatiana Guimarães Teixeira; William Pereira Alves; Vivian Jordania da Silva; Robin B Gasser; Élida Mara Leite Rabelo
Journal:  Parasitol Res       Date:  2019-01-29       Impact factor: 2.289

7.  Population Pharmacokinetics and Exposure-Response Analysis of Tribendimidine To Improve Treatment for Children with Hookworm Infection.

Authors:  Marc Pfister; Jennifer Keiser; Janneke M Brussee; Noemi Hiroshige; Anna Neodo; Jean T Coulibaly
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

8.  Pharmacometric Analysis of Tribendimidine Monotherapy and Combination Therapies To Achieve High Cure Rates in Patients with Hookworm Infections.

Authors:  Janneke M Brussee; Anna Neodo; Jessica D Schulz; Jean T Coulibaly; Marc Pfister; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

9.  Metabolomic profiling of the excretory-secretory products of hookworm and whipworm.

Authors:  Phurpa Wangchuk; Konstantinos Kouremenos; Ramon M Eichenberger; Mark Pearson; Atik Susianto; David S Wishart; Malcolm J McConville; Alex Loukas
Journal:  Metabolomics       Date:  2019-06-28       Impact factor: 4.290

10.  Cooperative Metabolic Adaptations in the Host Can Favor Asymptomatic Infection and Select for Attenuated Virulence in an Enteric Pathogen.

Authors:  Karina K Sanchez; Grischa Y Chen; Alexandria M Palaferri Schieber; Samuel E Redford; Maxim N Shokhirev; Mathias Leblanc; Yujung M Lee; Janelle S Ayres
Journal:  Cell       Date:  2018-08-09       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.